| Is Morgan Stanley wrong about big Palantir valuation markdown? Investment research firm PrivCo says its research shows Palantir is growing in value, not declining.
Theranos ran blood tests despite knowing of quality problems, report says A new report says Palo Alto company continued doing tests at its Newark lab despite erratic results from quality control tests last year.
Cisco buys S.F. cloud search business The company came out of the enterprise-focused Alchemist Accelerator in the fall of 2013.
Fresh targets, $43M in new funding sharpen ex-Onyx president's attack on cancer Startup Tizona Therapeutics looks to cut through the cancer immunotherapy clutter.
UserZoom aims for improved customer experiences with YouEye purchase San Jose-based UserZoom has raised $34 million so far, while YouEye raised $7.5 million before the acquisition.
VCs to share their views on state of startupland at March 16 Pitch event The event will be moderated by TechFlash Silicon Valley Editor Cromwell Schubarth and is at Google's Mountain View campus.
| 
